[go: up one dir, main page]

JPS52105220A - Composition for rectal administration comprising beta-lactam ring containing substance and method of making same - Google Patents

Composition for rectal administration comprising beta-lactam ring containing substance and method of making same

Info

Publication number
JPS52105220A
JPS52105220A JP2059076A JP2059076A JPS52105220A JP S52105220 A JPS52105220 A JP S52105220A JP 2059076 A JP2059076 A JP 2059076A JP 2059076 A JP2059076 A JP 2059076A JP S52105220 A JPS52105220 A JP S52105220A
Authority
JP
Japan
Prior art keywords
rectal administration
beta
composition
ring containing
containing substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2059076A
Other languages
Japanese (ja)
Other versions
JPS6055486B2 (en
Inventor
Hiroshi Kichijima
Junko Kitani
Tsutomu Uehara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyama Chemical Co Ltd
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Priority to JP2059076A priority Critical patent/JPS6055486B2/en
Publication of JPS52105220A publication Critical patent/JPS52105220A/en
Publication of JPS6055486B2 publication Critical patent/JPS6055486B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

PURPOSE: Preparations of β-lactam antibiatics for rectal administration, with higher rate of absorption in to the body and prolonged duration in the blood at high levels achieved by incorporation of probenecid.
COPYRIGHT: (C)1977,JPO&Japio
JP2059076A 1976-02-28 1976-02-28 Composition for rectal administration of a compound having a β-lactam ring Expired JPS6055486B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2059076A JPS6055486B2 (en) 1976-02-28 1976-02-28 Composition for rectal administration of a compound having a β-lactam ring

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2059076A JPS6055486B2 (en) 1976-02-28 1976-02-28 Composition for rectal administration of a compound having a β-lactam ring

Publications (2)

Publication Number Publication Date
JPS52105220A true JPS52105220A (en) 1977-09-03
JPS6055486B2 JPS6055486B2 (en) 1985-12-05

Family

ID=12031445

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2059076A Expired JPS6055486B2 (en) 1976-02-28 1976-02-28 Composition for rectal administration of a compound having a β-lactam ring

Country Status (1)

Country Link
JP (1) JPS6055486B2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5517342A (en) * 1978-07-25 1980-02-06 Toyama Chem Co Ltd Cephalosporin composition for rectal administaration
JPS5675437A (en) * 1979-11-21 1981-06-22 Asahi Denka Kogyo Kk Suppository base
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
WO2002041876A1 (en) * 2000-11-22 2002-05-30 Lupin Limited Pharmaceutical composition for controlled release of an active ingredient
WO2003043607A1 (en) * 2001-11-19 2003-05-30 Lupin Limited A pharmaceutical composition for controlled release of a beta-lactam antibiotic
CN100387574C (en) * 2004-12-01 2008-05-14 吴晓辉 Preparation technology of probenecid sodium and probenecid potassium
CN112076161A (en) * 2020-08-07 2020-12-15 安徽康正康仁药业有限公司 Compound freeze-dried preparation consisting of cephalosporin sodium salt and probenecid sodium

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5517342A (en) * 1978-07-25 1980-02-06 Toyama Chem Co Ltd Cephalosporin composition for rectal administaration
JPS5675437A (en) * 1979-11-21 1981-06-22 Asahi Denka Kogyo Kk Suppository base
JPS6220963B2 (en) * 1979-11-21 1987-05-11 Asahi Denka Kogyo Kk
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
WO2002041876A1 (en) * 2000-11-22 2002-05-30 Lupin Limited Pharmaceutical composition for controlled release of an active ingredient
WO2003043607A1 (en) * 2001-11-19 2003-05-30 Lupin Limited A pharmaceutical composition for controlled release of a beta-lactam antibiotic
US8192755B2 (en) 2001-11-19 2012-06-05 Lupin Limited Pharmaceutical composition for controlled release of a beta-lactam antibiotic
CN100387574C (en) * 2004-12-01 2008-05-14 吴晓辉 Preparation technology of probenecid sodium and probenecid potassium
CN112076161A (en) * 2020-08-07 2020-12-15 安徽康正康仁药业有限公司 Compound freeze-dried preparation consisting of cephalosporin sodium salt and probenecid sodium

Also Published As

Publication number Publication date
JPS6055486B2 (en) 1985-12-05

Similar Documents

Publication Publication Date Title
JPS52105220A (en) Composition for rectal administration comprising beta-lactam ring containing substance and method of making same
JPS5218811A (en) Preparation of aqueous solution of fat- soluble substances
JPS52125630A (en) Antiperkinson drugs containing l-threo-3,4-dihydroxyphenylserine
JPS5352622A (en) Composition for preparation of bordeaux mixture
JPS56104813A (en) Composition for rectal infusion containing compound having beta-lactam ring
JPS5346949A (en) 1-haldgenotricyclo(4,3,1,12,5)undecanes and their preparation
JPS51136886A (en) New biologica lly active substance, ml-236c, and its preparation
JPS53103329A (en) Magnetic bubble device
JPS5346950A (en) (54)1-acetylaminotricyclo(4,3,1,12,5)undecane and its preparation
JPS5359095A (en) Preparation of 7-aminocephem cpds.
JPS52151716A (en) Stabilization of mitomycin c
JPS51127636A (en) Watch dog timer
JPS51137425A (en) Optical device
JPS5318551A (en) 4-homoprotoadamantane and its preparation
JPS5272892A (en) Preparation of novel anti-biotic substance bn-165
JPS5339179A (en) Thermal luminescence dosemeter
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
JPS5334763A (en) Isolongifolene-6-ol, perfume composition containing the same and their preparation
JPS5235201A (en) Decoloration and deodorization of beeswax
JPS5321187A (en) Cephalosporin compounds and their preparation
JPS5315494A (en) 7-(4-carboxybutylamide)-7-methxycephalosporin derivatives and their preparation
JPS5312878A (en) Preparation of cyanopyrazinecarboxyamide and its preparation
JPS55147220A (en) Hemostatic and thrombocyte number increaser comprising alpha,beta-diaminopropionic acid
JPS5287187A (en) Preparation of 7-alkoxycephalosporin derivatives
JPS5416497A (en) Aminooxopyrrolopyrazine compounds and their preparation